SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-16-424363
Filing Date
2016-01-08
Accepted
2016-01-08 11:40:29
Documents
2
Effectiveness Date
2016-01-08

Document Format Files

Seq Description Document Type Size
1 DEFA14A d113679ddefa14a.htm DEFA14A 18680
2 GRAPHIC g113679g05u45.jpg GRAPHIC 11537
  Complete submission text file 0001193125-16-424363.txt   30444
Mailing Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024
Business Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024 (424) 248-6500
PUMA BIOTECHNOLOGY, INC. (Filer) CIK: 0001401667 (see all company filings)

IRS No.: 770683487 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-35703 | Film No.: 161332080
SIC: 2834 Pharmaceutical Preparations